POTENTIAL IMPACTS OF PHARMACEUTICAL USES OF TRANSGENIC TOBACCO: THE CASE OF HUMAN SERUM ALBUMIN (HSA)

The potential size and distribution of benefits from transgenic tobacco as a source of human serum albumin are estimated using an economic surplus model with imperfect competition. The results demonstrate that new products from bio-pharming applications stand to generate significant social benefits.

MoreLess

Year of publication:	2004
Authors:	Kostandini, Genti ; Mills, Bradford F. ; Norton, George W.
Institutions:	Agricultural and Applied Economics Association - AAEA
Keywords:	Research and Development/Tech Change/Emerging Technologies

More details

Extent:	application/pdf
Series:	2004 Annual meeting, August 1-4, Denver, CO.
Type of publication:	Book / Working Paper
Notes:	The text is part of a series 2004 Annual meeting, August 1-4, Denver, CO Number 20289
Source:	RePEc - Research Papers in Economics

Persistent link: https://www.econbiz.de/10005500459